# Christos Toumpanakis

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/christos-toumpanakis/

## Facts

| Field | Value |
| --- | --- |
| Citations | 8,424 |
| Field | Neuroendocrine Tumor Research Advances |
| h-index | 45 |
| i10-index | 107 |
| OpenAlex ID | https://openalex.org/A5010371525 |
| ORCID iD | 0000-0002-1152-7727 |
| Works | 350 |

## Researcher papers

- [Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids](https://scholariq.org/papers/pulmonary-neuroendocrine-carcinoid-tumors-european-neuroendocrine-tumor-society/)
- [ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas](https://scholariq.org/papers/enets-consensus-guidelines-for-high-grade-gastroenteropancreatic-neuroendocrine/)
- [ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum](https://scholariq.org/papers/enets-consensus-guidelines-update-for-neuroendocrine-neoplasms-of-the-jejunum/)
- [ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues](https://scholariq.org/papers/enets-consensus-guidelines-for-the-standards-of-care-in-neuroendocrine-neoplasms/)
- [ENETS Consensus Guidelines for Neuroendocrine Neoplasms of the Appendix (Excluding Goblet Cell Carcinomas)](https://scholariq.org/papers/enets-consensus-guidelines-for-neuroendocrine-neoplasms-of-the-appendix/)
- [ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours](https://scholariq.org/papers/enets-consensus-guidelines-for-the-standards-of-care-in-neuroendocrine-tumours/)
- [Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors](https://scholariq.org/papers/diagnosing-and-managing-carcinoid-heart-disease-in-patients-with-neuroendocrine/)
- [Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues](https://scholariq.org/papers/phase-iii-study-of-pasireotide-long-acting-release-in-patients-with-metastatic/)
- [Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor](https://scholariq.org/papers/prognostic-impact-of-novel-molecular-subtypes-of-small-intestinal-neuroendocrine/)
- [Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours](https://scholariq.org/papers/chemotherapy-with-5-fluorouracil-cisplatin-and-streptozocin-for-neuroendocrine/)
- [Outcomes, risks and complications of cardiac surgery for carcinoid heart disease](https://scholariq.org/papers/outcomes-risks-and-complications-of-cardiac-surgery-for-carcinoid-heart-disease/)

## Researcher topics

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Gastrointestinal Tumor Research and Treatment](https://scholariq.org/topics/gastrointestinal-tumor-research-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.